J&J Adds Cortaid, Insight Gets Bonine In Pfizer/Pharmacia Pre-Merger Sell Off
This article was originally published in The Tan Sheet
Johnson & Johnson will add Pharmacia's Cortaid OTC anti-itch and rash line to its skin remedies business in one of several divestitures planned to resolve Federal Trade Commission concerns regarding potential monopolies resulting from the merger of Pharmacia and Pfizer
You may also be interested in...
Johnson & Johnson divests another non-core consumer health brand – e.p.t. pregnancy tests – as the remediation of its OTC business continues.
Chattem is eyeing the OTC cough/cold and gastrointestinal tract categories as possible areas for expansion through acquisition, President & Chief Operating Officer Alec Taylor said at a BB&T Capital Markets Equity Research Conference in Leesburg, Va. May 21
Pfizer will expand its Consumer Healthcare facilities in Morris Plains, N.J. by adding 900,000 square feet over the next five years, the company said in a 1May 2 statement